CMS’ Proposed Drug Payment Rule Change Analyzed

In an article posted on morningconsult.com, Caitlin Owens provides an analysis of the Centers for Medicare and Medicaid Services’ proposed ruling that would impose new payment logic on drug reimbursements. It’s a two-part rule proposal, one part focused on the structure of drug reimbursement payments under Medicare Part B, the other addressing “value-based purchasing tools.” Read Ms. Owens’ article here…

Notice: The link provided above connects readers to the full content of the posted article. The URL (internet address) for this link is valid on the posted date; medicarereport.org cannot guarantee the duration of the link’s validity. Also, the opinions expressed in these postings are the viewpoints of the original source and are not explicitly endorsed by AMAC, Inc.; the AMAC Foundation, Inc.; or medicarereport.org.